Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
NCT Number: NCT02724462
The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98109, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimental arm includes an intervention using a novel smartphone smoking cessation app.
The control intervention uses a standard of care smartphone smoking cessation app.
Time frame: 12 months post randomization
Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are excluded for the complete-case analysis. Exact 2-sided CI was based on the observed proportion of participants.
Time frame: 12 months post randomization
Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are imputed as still smoking. Exact 2-sided CI was based on the observed proportion of participants.
Fred Hutchinson Cancer Center
Other
Randomized Trial of An Innovative Smartphone Intervention for Smoking Cessation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05490251
Behavior, Fractures, Bone
Los Angeles, California, United States
View Trial DetailsNCT04532970
Behavior, Blood-Borne Infections
Gaborone, Botswana
View Trial DetailsNCT04505371
Behavior, Blood-Borne Infections
Seattle, Washington, United States
View Trial DetailsNCT06051474
Behavior, Health Behavior
Madison, Wisconsin, United States
View Trial Details